CATALOGO DEI PRODOTTI DELLA RICERCA

MAURELLI, MARTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.182
NA - Nord America 987
AS - Asia 706
SA - Sud America 51
AF - Africa 36
OC - Oceania 11
Totale 2.973
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 970
CN - Cina 252
SG - Singapore 241
IT - Italia 203
RU - Federazione Russa 163
DE - Germania 154
IE - Irlanda 148
GB - Regno Unito 130
FR - Francia 114
SE - Svezia 110
FI - Finlandia 79
JP - Giappone 51
BR - Brasile 42
IN - India 41
ID - Indonesia 35
TG - Togo 25
KR - Corea 23
NL - Olanda 19
HK - Hong Kong 17
UA - Ucraina 14
BE - Belgio 12
AT - Austria 9
CA - Canada 9
ES - Italia 9
TR - Turchia 9
MX - Messico 8
AU - Australia 7
EG - Egitto 7
IR - Iran 7
IL - Israele 4
NZ - Nuova Zelanda 4
AR - Argentina 3
HU - Ungheria 3
LK - Sri Lanka 3
SA - Arabia Saudita 3
VN - Vietnam 3
BD - Bangladesh 2
BH - Bahrain 2
CH - Svizzera 2
CL - Cile 2
CZ - Repubblica Ceca 2
GE - Georgia 2
KE - Kenya 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
AM - Armenia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BW - Botswana 1
CO - Colombia 1
EC - Ecuador 1
HR - Croazia 1
IQ - Iraq 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MY - Malesia 1
OM - Oman 1
PK - Pakistan 1
PL - Polonia 1
RS - Serbia 1
TW - Taiwan 1
UY - Uruguay 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 2.973
Salva come PNG Salva come JPEG
Città #
Chandler 244
Singapore 168
Dublin 136
Ashburn 107
Southend 87
Munich 78
Beijing 69
Helsinki 62
Jacksonville 42
Verona 37
New York 35
Lawrence 34
Princeton 34
Wilmington 28
Jakarta 27
Lomé 25
Sindelfingen 20
Woodbridge 19
Milan 18
Washington 18
Monza 16
Hong Kong 15
Jinan 15
Amsterdam 12
Dallas 12
Los Angeles 12
Seattle 12
Bethnal Green 11
Ghaziabad 11
Rome 11
Ann Arbor 10
Frankfurt am Main 10
Houston 10
Santa Clara 10
Bologna 9
Liverpool 9
Dongguan 8
Guangzhou 8
Lappeenranta 8
Nanjing 8
Nuremberg 8
Redwood City 8
Chieri 7
Fairfield 7
Giza 7
Marseille 7
Mumbai 7
Wakabadai 7
Boston 6
Brussels 6
Igusa 6
Minamimotomachi 6
Moscow 6
Shanghai 6
Bari 5
Brindisi 5
Gurugram 5
Hanover 5
Jyväskylä 5
Konya 5
Redmond 5
Shenyang 5
Tokyo 5
Changsha 4
Chennai 4
Hebei 4
Jiaxing 4
Kent 4
Liège 4
London 4
Luoyang 4
Montreal 4
Nanchang 4
Paris 4
Seoul 4
Tianjin 4
Auckland 3
Barcelona 3
Berlin 3
Canberra 3
Chicago 3
Colombo 3
Council Bluffs 3
Dearborn 3
Düsseldorf 3
Esslingen am Neckar 3
Fuzhou 3
Hangzhou 3
Jeddah 3
Kolkata 3
Madrid 3
Miami 3
Ningbo 3
Norwalk 3
Oakland 3
Oullins 3
Povegliano Veronese 3
San Diego 3
Shahr-e Kord 3
Toronto 3
Totale 1.768
Salva come PNG Salva come JPEG
Nome #
A risankizumab super responder profile identified by long-term real-life observation-IL PSO (ITALIAN LANDSCAPE PSORIASIS) 194
A systematic review of treatments for pityriasis lichenoides 190
Incidence and ten-year follow-up of primary cutaneous lymphomas: a single-centre cohort study 82
null 80
Long-term therapeutic response to dupilumab in patients affected by prurigo nodularis: A real-world retrospective study 77
Upadacitinib improves symptoms of concomitant allergic rhinitis or allergic asthma in patients with severe atopic dermatitis: A 16-week multicentre retrospective study 75
BRAF V600E expression in juvenile xanthogranuloma occurring after Langerhans cell histiocytosis. 73
Clinical features and treatments of transient acantholytic dermatosis (Grover’s disease): a systematic review 71
Clinical and immunological profile of patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid 68
Amicrobial Pustulosis of the Folds: Report of Three New Cases 67
Neutrophilic figurate erythema: report of a new case in an adult and comparison between adult and paediatric cases 66
Primary Cutaneous CD4+ Small/Medium Pleomorphic T-Cell Lymphoproliferative Disorder: A Case Series 64
Alopecic and aseptic nodules of the scalp: A new case with a systematic review of the literature 64
Psoriasin (S100A7) is increased in serum of patients with moderate to severe psoriasis 63
Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors: A case series 62
Acquired perforating dermatoses show increased levels of cutaneous advanced glycation end-products 60
Persistent localized hypertrichosis in a Caucasian child at sites of DTPa and chickenpox vaccination 56
Dupilumab improves clinical manifestations, symptoms, and quality of life in adult patients with chronic nodular prurigo 56
Idiopathic lichenoid and granulomatous dermatitis 56
A case of genital primary syphilis with superimposed impetigo 54
Adrenergic urticaria successfully treated with omalizumab 53
Interferon-beta injection site reactions in patients with multiple sclerosis. 52
Annular Erythema: New and Revisited Variants 52
Biological agents targeting interleukin-13 for atopic dermatitis 52
Annually Recurring Erythema Annulare Centrifugum: A New Case Series with Review of the Literature 51
Milia-like calcinosis cutis in Down syndrome: a new case with a review of the literature 50
Severe cutaneous aluminum reaction to quadrivalent human papillomavirus vaccine treated with cyclosporin 48
Cutaneous Adverse Reactions Associated with SARS-CoV-2 Vaccines 47
Cost per Responder Analysis of Secukinumab versus Adalimumab in the Treatment of Psoriatic Disease 47
Drug survival of dupilumab compared to cyclosporin in moderate-to-severe atopic dermatitis patients 46
Clinical profile and co-infections of urethritis in males 46
Eosinophilic annular erythema successfully treated with cyclosporine 45
IL-17A inhibitors in patients with chronic plaque psoriasis and history of malignancy: A case series with systematic literature review 42
A man with a widespread bullous eruption 39
Uncommon Non‑Infectious Annular Dermatoses 39
Reducing the Risk of Developing Psoriatic Arthritis in Patients with Psoriasis 39
Cost per responder of Adalimumab biosimilars MSB11022 and ABP 501 versus the originator and methotrexate in chronic plaque psoriasis 38
Palisaded neutrophilic granulomatous dermatitis and its associations with autoimmune diseases 38
Lichen planopilaris coexisting with plaque psoriasis effectively treated with brodalumab 37
Long‑Term Effectiveness and Safety of Ixekizumab for the Treatment of moderate‑to‑Severe Plaque Psoriasis: A Five‑Year Multicenter Retrospective Study—IL PSO (Italian Landscape Psoriasis) 34
Advanced Glycation End Products and Psoriasis 33
Visual Vignette 33
Targeting IL-4 for the Treatment of Atopic Dermatitis 33
Atopic Dermatitis in the Elderly Population 32
Pruritus as a Distinctive Feature of Type 2 Inflammation 32
The emerging role of the neuroimmune cytokine interleukin-31 in chronic inflammatory skin diseases 31
Price variability of TNF-α inhibitor biosimilars among European countries 30
Advanced Glycation End Products are Increased in the Skin and Blood of Patients with Severe Psoriasis 28
Real-Life Effectiveness of Adalimumab Biosimilars in Patients with Chronic Plaque Psoriasis 28
Variations of symptoms of atopic dermatitis and psoriasis in relation to menstrual cycle 28
Reduction of cutaneous advanced glycation end products levels after effective psoriasis treatment 27
Tailored biological treatment for patients with moderate-to-severe psoriasis 25
Is risankizumab as needed administration a good option for patients with plaque psoriasis? 25
Lymphoplasmacytic plaque effectively treated with imiquimod 25
Managing the Patient with Psoriasis and Metabolic Comorbidities 21
Identification of clinical predictors for dupilumab dose spacing in adults with atopic dermatitis: a real-world study 21
The Combination of Dupilumab with Other Monoclonal Antibodies 21
Cost per responder of adalimumab biosimilars versus methotrexate in patients with psoriasis: a real-life experience 19
Overview of Atopic Dermatitis in Different Ethnic Groups 18
Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study—IL PSO (ITALIAN LANDSCAPE PSORIASIS) 18
Long-term effectiveness and tolerability of apremilast in patients with moderate-to- severe plaque psoriasis: A 5-year multicentre retrospective study—IL PSO (Italian landscape psoriasis) 16
Prevalence of Non-Alcoholic Fatty Liver Disease in Adult Individuals with Moderate-to-Severe Atopic Dermatitis 15
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study 13
Short-term effectiveness and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis: results from a 16-week real-world multicenter retrospective study – il AD (Italian landscape atopic dermatitis 12
Totale 3.057
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.342
article - articoli 15.061
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 281
Totale 30.684
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202047 0 0 0 0 0 0 0 0 5 13 16 13
2020/2021127 13 13 3 21 19 16 10 1 6 2 13 10
2021/2022228 13 26 0 18 31 6 6 23 4 14 30 57
2022/2023738 38 68 63 134 58 187 16 34 90 13 25 12
2023/2024647 16 30 56 51 52 126 115 42 8 39 71 41
2024/20251.088 119 63 98 291 80 115 168 111 43 0 0 0
Totale 3.057